[1] K. Scheidhauer, C. Seidl, F. Bruchertseifer, et al. “Bi-213-anti-EGFR-MAb therapy of recurrent bladder cancer - a pilot study.” Eur J Nucl Med Mol Imaging (2017) 44(Suppl 2):S130. The gene discussed is EGFR; the disease is urinary bladder cancer.